CIK 0001622229
- Large accelerated filer
Cogent Biosciences, Inc.
Sign in to watch- Ticker
- COGT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 465308248
- Phone
- +1 617-945-5576
- Business address
- 180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
- Former names
- Unum Therapeutics Inc., Unum Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,689,493
- in 1 filing, $1.7M under 10b5-1 plans
Net −$1,689,493. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-09 | Ros Matthew Director | Grant or award · Stock Option (Right to Buy) | +17,901 | 17,901 | ||
| 2025-06-04 | Ros Matthew Director | Grant or award · Stock Option (Right to Buy) | +44,700 | 44,700 | ||
| 2024-06-05 | Ros Matthew Director | Grant or award · Stock Option (Right to Buy) | +44,700 | 44,700 | ||
| 2024-01-02 | Ros Matthew Director | Grant or award · Stock Option (Right to Buy) | +3,051 | 3,051 | ||
| 2023-10-02 | Ros Matthew Director | Grant or award · Stock Option (Right to Buy) | +2,170 | 2,170 | ||
| 2023-07-03 | Ros Matthew Director | Grant or award · Stock Option (Right to Buy) | +1,743 | 1,743 | ||
| 2023-06-07 | Ros Matthew Director | Grant or award · Stock Option (Right to Buy) | +36,700 | 36,700 | ||
| 2023-04-03 | Ros Matthew Director | Grant or award · Stock Option (Right to Buy) | +1,900 | 1,900 | ||
| 2023-01-03 | Ros Matthew Director | Grant or award · Stock Option (Right to Buy) | +1,792 | $7.19 | $13K | 1,792 |
| 2022-10-03 | Ros Matthew Director | Grant or award · Stock Option (Right to Buy) | +1,419 | $9.08 | $13K | 1,419 |
| 2022-07-01 | Ros Matthew Director | Grant or award · Stock Option (Right to Buy) | +2,194 | $5.87 | $13K | 2,194 |
| 2022-06-07 | Ros Matthew Director | Grant or award · Stock Option (Right to Buy) | +30,700 | 30,700 | ||
| 2022-04-01 | Ros Matthew Director | Grant or award · Stock Option (Right to Buy) | +2,650 | $4.86 | $13K | 2,650 |
| 2022-01-03 | Ros Matthew Director | Grant or award · Stock Option (Right to Buy) | +2,256 | $5.15 | $12K | 2,256 |
| 2021-10-01 | Ros Matthew Director | Grant or award · Stock Option (Right to Buy) | +2,463 | $5.03 | $12K | 2,463 |
| 2021-07-01 | Ros Matthew Director | Grant or award · Stock Option (Right to Buy) | +2,225 | $4.78 | $11K | 2,225 |
| 2021-04-01 | Ros Matthew Director | Grant or award · Stock Option (Right to Buy) | +2,068 | $5.66 | $12K | 2,068 |
| 2021-03-11 | Ros Matthew Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2021-01-04 | Ros Matthew Director | Grant or award · Stock Option (Right to Buy) | +1,641 | 1,641 | ||
| 2020-10-01 | Ros Matthew Director | Grant or award · Stock Option (Right to Buy) | +9,247 | $1.35 | $13K | 9,247 |
Page 1 of 2 · 26 trades